2'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.

doi:10.1016/j.ejphar.2012.09.027

Paper

2'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.

Published Dec 5, 2012 · J. Kwon, Su-Hyung Hong, Sun-Dong Park

European journal of pharmacology

Q1 SJR score

22

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

2'-benzoyloxycinnamaldehyde (BCA) effectively inhibits nitric oxide production in RAW 264.7 cells, suggesting its potential as an anti-atherosclerotic agent with less cytotoxicity.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

2'-Benzoyloxycinnamaldehyde inhibits nitric oxide production in lipopolysaccharide-stimulated RAW 264.7 cells via regulation of AP-1 pathway.

References

Citations